News Conference News ACC 2026 Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease Todd Neale April 01, 2026
News Conference News ACC 2026 Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI Todd Neale March 30, 2026
News Conference News ACC 2026 Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI Yael L. Maxwell March 30, 2026
News Conference News ACC 2026 Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV Caitlin E. Cox March 30, 2026
News Conference News ACC 2026 Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3 Yael L. Maxwell March 29, 2026
News Daily News Benefits of Early SAVR for Asymptomatic Aortic Stenosis Persist a Decade On Todd Neale March 26, 2026
News Daily News FDA Approves JenaValve’s Trilogy for Aortic Regurgitation Michael O'Riordan March 23, 2026
News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide L.A. McKeown March 19, 2026
News Daily News Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines Caitlin E. Cox March 18, 2026
News Conference News CRT 2026 PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years L.A. McKeown March 17, 2026
News Conference News CRT 2026 CARPOOL Radial Access as Good as Femoral in PAD Procedures L.A. McKeown March 16, 2026
News Conference News CRT 2026 SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type L.A. McKeown March 16, 2026
News Daily News Experience Matters as Ross Procedure Gains Popularity in North America Michael O'Riordan March 06, 2026
News Daily News Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD Caitlin E. Cox March 06, 2026
News Conference News THT 2026 NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER Todd Neale March 04, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2026 Michael O'Riordan March 02, 2026
News Conference News EAPCI 2026 AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing Caitlin E. Cox February 25, 2026
News Daily News Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial Michael O'Riordan February 19, 2026